The importance of HPV vaccination
Human papillomavirus (HPV) is a common virus that is easily transmitted through skin-to-sex contact. Some species of this virus are dangerous and if left untreated, it can cause diseases such as genital warts, cervical cancer, anal cancer, etc. Species 16 and 18 of this virus cause 70% of cervical cancers. Cervical cancer is the fourth most common cancer in women. 530,000 new patients are diagnosed each year, resulting in 275,000 deaths, more than 85% of which are in developing countries.
Safety studies on the HPV vaccine have been conducted in thousands of women around the world before being licensed. The results of the studies showed that the vaccines are well tolerated without any worries. Millions of women have received the HPV vaccine since it was licensed. The most common side effects reported in vaccinated chickens include injection site reactions such as pain, redness, and swelling. Other commonly reported side effects include fatigue, headache, muscle aches, gastrointestinal symptoms, and arthritis. In order to manage allergic reactions, it is recommended that the person sit during the vaccine injection and then be monitored for 15 minutes.
The main target population for this vaccine is girls 9 to 13 years old, but it is also recommended for all people up to 26 years old who have not been vaccinated before. People who receive the first dose before the age of 15, in a 2-dose schedule; The second dose should be given 6 to 12 months after the first dose (schedule 0, 6-12 months). People who receive the first dose after the age of 15 and for people with special immune conditions, 3 doses in one program; The second dose should be given 1 month after the first dose and the third dose should be given 6 months after the first dose (schedule 0, 1, 6 months).
What diseases can Papilloguard® help to prevent?
In girls from the age 9, helps to prevent:
• Cervical cancer
• Vulvar and vaginal cancers
• Anal cancer
• Precancerous cervical, vulvar, vaginal and anal lesions
• Cervical Cancer
• Cervical Precancer
• Oropharyngeal Cancer
• Anal Cancer
• Vulvar & Vaginal Cancer
• Penile Cancer
In 2018, approximately 569,847 new cases were diagnosed worldwide and were responsible for 311,365 deaths (2).
85% of cervical cancer deaths occur in low and middle-income countries.
Virtually all cases are linked to genital infection with the human papillomavirus (HPV) (2).
Immunogenicity and safety of a bivalent, adjuvant system 04–adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15–25: a randomized, double-blind, phase III, noninferiority clinical trial